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STUDY PROTOCOL
A study protocol for a randomised controlled 
feasibility trial of an intervention to increase 
activity and reduce sedentary behaviour 
in people with severe mental illness: Walking 
fOR Health (WORtH) Study
Suzanne M. McDonough1,2,3*†, Sarah C. Howes1† , Maurice Dillon4, Judith McAuley5, John Brady6, 
Mary Clarke7, Mike Clarke8, Emily Lait9, Duana McArdle4, Tony O’Neill8,10, Iseult Wilson11, Ailsa Niven12, 
Julie Williams13, Mark A. Tully14, Marie H. Murphy15 and Catherine M. McDonough16 
Abstract 
Background: People with severe mental illness (SMI) are less physically active and more sedentary than healthy con-
trols, contributing to poorer physical health outcomes in this population. There is a need to understand the feasibility 
and acceptability, and explore the effective components, of health behaviour change interventions targeting physical 
activity and sedentary behaviour in this population in rural and semi-rural settings.
Methods: This 13-week randomised controlled feasibility trial compares the Walking fOR Health (WORtH) multi-com-
ponent behaviour change intervention, which includes education, goal-setting and self-monitoring, with a one-off 
education session. It aims to recruit 60 inactive adults with SMI via three community mental health teams in Ireland 
and Northern Ireland. Primary outcomes are related to feasibility and acceptability, including recruitment, retention 
and adherence rates, adverse events and qualitative feedback from participants and clinicians. Secondary outcome 
measures include self-reported and accelerometer-measured physical activity and sedentary behaviour, anthropom-
etry measures, physical function and mental wellbeing. A mixed-methods process evaluation will be undertaken. This 
study protocol outlines changes to the study in response to the COVID-19 pandemic.
Discussion: This study will address the challenges and implications of remote delivery of the WORtH intervention 
due to the COVID-19 pandemic and inform the design of a future definitive randomised controlled trial if it is shown 
to be feasible.
Trial registration: The trial was registered on clini caltr ials. gov (NCT04 134871) on 22 October 2019.
Keywords: Physical activity, Sedentary behaviour, Behaviour change, Severe mental illness
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Background
People with severe mental illness (SMI) experience a 
higher prevalence of preventable physical health condi-
tions compared to the general population [1]. In particu-
lar, people with SMI, such as schizophrenia-spectrum 
disorders, bipolar disorder and major depressive disorder, 
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have a risk of cardiovascular and metabolic diseases 1.4–
2.0 times higher than the general population [2]. Lon-
gitudinal data indicates that people with SMI are more 
likely to have two or more comorbidities, with greater 
increases in the prevalence of comorbidities over time in 
people with SMI compared with the general population 
[1]. Alongside factors including genetic risk and the side 
effects of anti-psychotic medications, the high prevalence 
of cardiometabolic-related morbidity and mortality in 
SMI has been associated with modifiable lifestyle factors, 
including reduced physical activity and high levels of sed-
entary behaviour [3].
Systematic review evidence has shown that people with 
SMI are less physically active and spend more time in 
sedentary behaviour than healthy controls [4–9]. They 
complete less moderate to vigorous physical activity than 
controls [9], with up to 70% not meeting physical activity 
guidelines [4, 10]. They also spend 8–11 h per day sitting 
or lying down, which represents more time in sedentary 
behaviour than healthy controls [4, 5, 7–9]. Higher levels 
of sedentary behaviour in SMI have been associated with 
poorer metabolic outcomes [11], while increased physical 
activity improves cardiometabolic risk [12]. Interventions 
that support those who are inactive to replace sedentary 
time with small amounts of physical activity are likely 
to reduce the incidence and impact of cardiometabolic 
comorbidities in people with SMI [13–15].
Barriers to being active experienced in the general 
population, such as time constraints and physical health 
concerns, are compounded in people with SMI due to 
their mental health symptoms. People with SMI report 
physical barriers, such as tiredness, low energy and 
sedative effects of their medications; psychological bar-
riers, such as stress, depression and amotivation; and 
social and environmental barriers, such as lack of sup-
port and social isolation [16–18]. Given these barriers, 
and the high levels of inactivity in people with SMI, 
walking has been recommended as one of the simplest 
ways of increasing physical activity [19]. Systematic 
review evidence shows small, short-term effects of walk-
ing on weight reduction (n = 10 trials, 339 participants) 
[20], and recent feasibility evidence by members of our 
team [21] showed that a walking-based intervention to 
increase physical activity and reduce sedentary behav-
iour in adults with SMI was feasible and acceptable, with 
positive findings in recruitment, retention, adherence 
and participant feedback and preliminary evidence for 
an increase in physical activity levels and reduction in 
sedentary behaviour in the intervention compared to the 
control group.
Although the study by Williams et al. [21] contributes 
to the developing knowledge base on walking interven-
tions in people with SMI, it was conducted in a densely 
populated urban setting. Environmental design features 
of large cities, such as the walkability of streets, prox-
imity of destinations and density of shops and services 
close to the home, strongly influence the likelihood of 
walking [22]. Conversely, residents of rural and semi-
rural areas have to overcome additional unique barriers 
to engage in regular walking, such as a greater disper-
sion of housing, infrastructure and services leading to 
increased car-dependency and concerns about personal 
safety, for example walking on unlit rural roads without 
footpaths [23]. As such, an urban-based intervention 
may not be directly transferable.
This randomised controlled feasibility study aims to 
assess the feasibility and acceptability of a multi-com-
ponent behaviour change intervention and explore its 
efficacy in improving physical activity and sedentary 
behaviours in adults with SMI living in rural and semi-
rural environments. It also aims to explore effective 
intervention components to support health behaviour 
change in this study population. Findings will be used 
to optimise design of a main fully powered trial.
Aims and objectives
Aim
To test the feasibility of a multi-component behaviour 
change intervention aimed at increasing physical activ-
ity and reducing sedentary behaviour compared with a 
one-off education session in people with SMI living in 
rural and semi-rural locations.
Objectives
 i. To determine the recruitment, retention and 
adherence rates in both trial arms and explore rea-
sons for these rates.
 ii. To determine the acceptability of the intervention 
in terms of the incidence of adverse events and 
level of overall satisfaction in both groups.
 iii. To estimate variability in clinical markers to inform 
the design of future effectiveness studies (calculate 
effect sizes for change in physical activity, seden-
tary behaviour and cardiometabolic risk factors, 
including BMI and waist circumference).
 iv. To conduct a process evaluation according to MRC 
guidance [24] to explore potential mediators of 
behaviour change (motivation to exercise and 
psychological needs satisfaction), to determine 
requirements for clinical staff to deliver the inter-
vention, and service users views of the interven-
tion.
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Methods
This section describes the planned methodology; changes 
made due to the COVID-19 pandemic are summarised 
later in Table 2.
Study design
This feasibility study is a 13-week randomised controlled 
trial comparing the Walking fOR Health (WORtH) inter-
vention, a group-based intervention including education, 
goal-setting, self-monitoring, and group walks, with a 
control consisting of a single education session during 
which participants receive written and verbal informa-
tion on the benefits of being more active. A logic model 
detailing how the WORtH intervention may achieve its 
proposed outcome is presented in Fig. 1.
Setting
The intervention will take place within the mental health 
service in two health care trusts in Northern Ireland (NI) 
and one in the Republic of Ireland (RoI).
Approval
Ethical approval for the trial has been obtained from the 
Office for Research and Ethics Committees NI (IRAS ID: 
250401) and the Health and Social Care Executive Dub-
lin North East Research Ethics Committee in RoI. Local 
research governance approval was obtained from the rel-
evant health care trusts. The trial has been registered on 
clini caltr ials. gov (NCT04134871).
Study population
This trial aims to recruit 60 participants: 30 in the inter-
vention group and 30 in the control group. A formal 
sample size calculation was not used for this feasibility 
study; it is anticipated that this sample size will provide 
sufficient information on the study objectives to inform a 
future main trial. The inclusion criteria will be adult par-
ticipants (male or female; aged ≥ 18 years) with a diagno-
sis of any SMI (schizophrenia, psychosis, bipolar disorder 
and major depression), not meeting the national physical 
activity guidelines. A validated questionnaire, the Gen-
eral Practice Physical Activity Questionnaire (GPPAQ), 
will be used to screen physical activity levels [25]. Exclu-
sion criteria will be those with significant movement 
impairment, those identified as ‘Active’ using the GPPAQ 
screening tool and those unable to understand English or 
who lack comprehension to understand the purpose of 
the study and give written informed consent. The revised 
Physical Activity Readiness Questionnaire (PAR-Q) [26] 
will be used to identify any health-related risks of exercis-
ing that would require a participant to consult their gen-
eral practitioner prior to changing their physical activity 
levels.
Recruitment
Recruitment to the trial will be via mental health teams 
in NI and ROI and will involve a number of strategies. 
The research team will work closely with the multidisci-
plinary mental health team clinicians and the Northern 
Ireland Clinical Research Network Mental Health group, 
where available, to identify service users who meet the 
Fig. 1 A logic model of the proposed effect of the WORtH intervention on health in individuals with SMI
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eligibility criteria. Recruitment will be via screening 
clinic lists, referral from existing services, such as groups, 
day-care services and residential facilities, and through 
posters displayed in communal and waiting areas. Ser-
vice users who meet the eligibility criteria will be given 
information about the study, either at a clinic visit or via 
post. Those who express an interest in taking part will 
be invited to meet with the researcher to complete the 
GPPAQ and PAR-Q and be given the opportunity to ask 
any questions they have about the study. Following this, if 
interested in participating in the study they will be asked 
to provide written consent.
Randomisation
Cluster randomisation will be used given that some par-
ticipants may be recruited from services such as groups, 
day centre or residential facilities. Each cluster will have 
a 1:1 probability of being allocated to intervention or 
control. The randomisation will be done by a researcher 
independent of the study and blind to the identity of the 
participants. A site will be ready for randomisation when 
all participants have consented and completed base-
line assessment. Random allocation to intervention or 
control will be done when a group of sites are ready for 
randomisation.
Intervention
Participants assigned to the WORtH intervention group 
will attend an initial educational group session where 
they will meet their clinician-coach, a clinician from the 
mental health team who has been trained to deliver the 
WORtH intervention. The content of the group educa-
tion session will introduce the benefits of increasing their 
physical activity and reducing their sedentary behaviour, 
along with strategies to help them to move more and sit 
less in their daily routines. During the session, partici-
pants will be given a physical activity monitor (Mi Band 
3, Xiaomi Corporation, Hong Kong) to self-monitor their 
daily steps throughout the intervention and an activity 
diary where they will record their physical activity and 
sedentary behaviour goals, complete their action plans 
and self-monitor by recording daily goal attainment.
Participants will be invited to attend a weekly group 
walk led by a clinician-coach; this will provide an element 
of social support. Additionally, they will meet with their 
assigned clinician-coach every 2 weeks. During coaching 
sessions, the participant will be supported to set move 
more (physical activity) and sit less (sedentary behaviour) 
goals which will be reviewed and progressed during the 
programme. Participants will be supported to complete 
an action plan of when, where and how they plan to meet 
their goals including strategies to overcome anticipated 
barriers discussed during the session.
The Behaviour Change Technique Taxonomy version 1 
(BCTTv1) [27] provides a standardised and well-defined 
taxonomy of active components of behaviour change that 
can be used in the design and evaluation of interventions 
[28]. This approach has been used by our team to develop 
and define a number of physical activity and sedentary 
behaviour interventions [29–32] and helped to inform 
the behaviour change techniques (BCTs) to embed within 
the WORtH intervention to promote increased physical 
activity and reduced sedentary behaviour in people with 
SMI. WORtH intervention components were mapped to 
the BCTTv1 [27] independently by two authors (SH and 
AN) to identify the BCTs targeting increased physical 
activity and reduced sedentary behaviour in people with 
SMI. A summary of the core BCTs embedded within the 
WORtH intervention is presented in Fig. 2.
Control
Participants assigned to the control group will be invited 
to attend a single one-to-one information session where 
they will be given an A5 leaflet briefly outlining the ben-
efits of being more active and reducing sedentary behav-
iour and advice on how to do so. During the session, the 
researcher will read through the leaflet with the partici-
pant and give them the opportunity to ask questions. The 
researcher will complete a pro-forma with details of the 
duration of the session and a checklist of information to 
be covered in the session. At the end of the session, they 
will be informed of the date of end of study assessment. 
Immediately after the session, the researcher will make a 
handwritten note of the conversation and comments.
Outcomes
Primary outcome
The feasibility and acceptability of the intervention will 
be evaluated in terms of recruitment, retention and 
adherence rates to the trial. Where available, reasons for 
these rates will be recorded (study objective I). A record 
will be kept of all information on instances of adverse 
events, including mental and physical problems and any 
reports of difficulty with intervention components (study 
objective II).
Secondary outcomes
The following outcomes will be measured at baseline and 
post-intervention, with a subset included at 6, 12, 18 and 
24 months follow-up (study objective III) as summarised 
in Fig. 3:
• Objective sedentary and physical activity time: All 
participants will be asked to wear a wrist-worn triax-
ial accelerometer (Axivity AX3, Open Lab, Newcas-
tle) for at least 4 days. The accelerometer will record 
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how many minutes per day each participant is sed-
entary and engages in light, moderate and vigorous 
physical activities. This study will explore the change 
in average minutes of sedentary behaviour and physi-
cal activity before and after the intervention (study 
objective III).
• Anthropometric measures: Body mass index will 
be measured in line with the International Diabetes 
Federation criteria [33], including height, weight and 
waist circumference.
• Self-report of physical activity and sedentary behav-
iour: The Simple Physical Activity Questionnaire 
(SIMPAQ) will be used to capture self-reported phys-
ical activity [34]. The SIMPAQ includes five items 
asking about estimated time in bed, structured exer-
cise participation and incidental or non-structured 
physical activity over the previous 7 days. The Seden-
tary Behaviour Questionnaire (SBQ) will be used to 
measure sedentary behaviour and has been shown to 
have good reliability [35].
• Mental well-being: Participants will be asked to com-
plete the Warwick-Edinburgh Mental Wellbeing 
Scale (WEMWBS), a 14-item self-report measure, to 
assess well-being [36]. Respondents rate their experi-
ence regarding each statement over the last 2 weeks. 
Each item is scored using a 5-point Likert scale rang-
ing from 1 (none of the time) to 5 (all of the time), 
with the total score ranging from 14 (low well-being) 
to 70.
• Functional mobility: Participants will be asked to 
complete a Timed Up-and-Go (TUG) test [37]. The 
TUG test requires participants to stand up from a 
chair, walk 3 m, turn around, walk back and sit down 
again. The time taken is measured in seconds, and 
scores represent functional mobility, with higher 
scores indicating increasing mobility difficulties. 
Times longer than 13.5 s are predictive of falls in the 
general older adult population.
• Motivation to engage in physical activity: Partici-
pants will be asked to complete the Behavioural 
Regulation in Exercise Questionnaire-2 (BREQ-2) 
which is a 19-item interviewer-administered ques-
tionnaire designed to consider an individual’s moti-
vation towards exercise [38]. The BREQ-2 has been 
validated in people with schizophrenia [39]. They will 
also be asked to complete the Psychological Needs 
Satisfaction and Exercise Scale (PNSE), an 18-item 
questionnaire that measures perceived competence, 
autonomy and relatedness experienced in exercise 
contexts [40].
At baseline, socio-demographic information will be 
collected, including age, gender, ethnicity, living arrange-
ments, pain level, smoking status, psychiatric diagnosis 
Fig. 2 Summary of behaviour change techniques included in the intervention
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and current medications. Additionally, at baseline, all 
participants complete the Montreal Cognitive Assess-
ment (MoCA) [41], a 30-item screening tool that is 
validated in SMI [42] and examines cognitive domains 
including executive functioning, attention and verbal flu-
ency. Scores < 26 are suggestive of cognitive impairment. 
This data will be used to understand the implications of 
cognitive impairment on intervention delivery and com-
pletion of outcome assessments.
For the post-intervention assessment, attempts will 
be made to follow all participants, including those who 
discontinue the intervention early. Follow-up assess-
ments at 6, 12, 18 and 24 months will be optional and will 
include the outcomes summarised in Fig. 3. Additionally, 
information on participants’ continuation with interven-
tion components after the end of the programme will be 
collected.
Fig. 3 SPIRIT schedule of enrolment, intervention and assessment
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Process evaluation (study objective IV): In addition 
to the outcome assessment, a qualitative process evalu-
ation will be conducted to explore participants’ experi-
ence of the intervention, factors influencing engagement 
with the intervention and intervention changes required. 
Qualitative data from semi-structured interviews will be 
considered alongside the BREQ-2 and PNSE measures to 
consider how motivational constructs may mediate the 
effects of the intervention on behaviour change.
The process evaluation will also explore how the clini-
cians delivering the coaching intervention experienced 
this; qualitative data collection will explore their ability to 
deliver the instructions as planned, including facilitators 
and barriers to the delivery, the sufficiency of the train-
ing and the support from the research team. Members of 
the wider mental health care team who are involved in 
supporting participants with aspects of the intervention 
will also be invited to a focus group, dyad or interview 
(depending on the availability of individuals) to explore 
the level of support required by participants and the chal-
lenges and facilitators to complete the intervention from 
their perspective.
To explore the extent to which the intervention is deliv-
ered as planned, clinician-coaches will be asked to audio-
record coaching sessions. Participants will be asked to 
consent to audio-recording of their coaching sessions. 
The audio-recordings will be reviewed alongside notes 
made in the study record forms by clinician-coaches doc-
umenting content of coaching session to assess delivery 
of the active components of the intervention against a 
study-specific pre-defined checklist based on the Borelli 
checklist [43, 44].
Data analysis
Statistical analysis will be performed using SPSS software. 
The data will be checked for normality, then appropriate 
descriptive analyses will be used to summarise participant 
characteristics and outcomes. Feasibility, the primary out-
come of this study, will be evaluated by calculating the 
percentage of people approached who participate in the 
intervention (recruitment) and the percentage who com-
plete the intervention (retention and adherence).
As this is a feasibility study, significance tests will not 
be performed on secondary outcomes, such as change 
in anthropometric measures, physical activity or sed-
entary time. Intervention effects will be represented by 
point estimates and their standard deviations. Point esti-
mates will be calculated by subtracting unadjusted mean 
data at each post-intervention timepoint from the mean 
data at the baseline timepoint. These will be used along 
with their standard deviations to estimate a sample size 
required for a definitive trial, if appropriate [45].
Qualitative data from interviews, dyads and focus 
groups will be transcribed verbatim, and interpretation, 
synthesis and data reduction will be undertaken indepen-
dently by two members of the research team to identify 
relevant themes. Qualitative findings will be used along-
side quantitative outcomes related to process evaluation 
(BREQ-2 and PNSE) to understand how the intervention 
was experienced by participants and any changes that 
they think would improve the intervention.
The traffic light system [46] will be used to guide pro-
gression to a main trial, as recommended in recent best 
practice, and will use the worst performing of the four 
elements in Table  1 to select which of the following 
actions to take:
Table 1 Criteria for progression to main trial
Red Amber Green
Recruitment
 % of target number of par-
ticipants recruited (target: 60; 
12 month recruitment period)
< 70% 70–99% 100%
Adherence
 % of recruited participants 
who adhere to their allocated 
intervention
< 65% 65–84% 85–100%
Retention
 % of recruited patients with 
follow-up data
< 65% 65–84% 85–100%
Signal of efficacy
 Results for primary clinical 
outcome and safety
CI for effect estimate for primary 
clinical outcome that does not 
include a clinically important differ-
ence or evidence of significant harm
CI for effect estimate for primary 
outcome that is mostly negative or 
evidence of potential harm
CI for effect estimate for primary 
outcome that is mostly positive and 
no evidence of potential harm
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Green: progress to main trial with a review of screen-
ing logs and protocol to address any barriers to recruit-
ment, adherence or retention.
Amber: progress to main trial after discussion with 
Trial Steering Committee/Trial Management Group with 
a full review of screening logs and protocol deviations to 
implement solutions to barriers to recruitment, adher-
ence or retention, and (if relevant) a review of feedback 
from participants and clinicians, and (if relevant) recon-
sideration of the intervention.
Red: probably not progress to main trial without sub-
stantial changes.
Implications of COVID-19 on study delivery
This study is being rolled out during the COVID-19 global 
pandemic. Therefore, current public health restrictions 
in place relating to COVID-19 will be followed, aiming 
to reduce in-person contact with participants to reduce 
the risk of transmission for patients and staff, where pos-
sible (Table  2). Recruitment to the study was open both 
pre- and post-suspension due to COVID-19; as such, par-
ticipants recruited to the trial pre-suspension were clus-
ter-randomised in a 1:1 ratio and received an in-person 
intervention, while participants recruited post-suspension 
are individually randomised in a 2:1 ratio and receive 
remote delivery of the intervention as outlined in Table 2.
Discussion
This randomised controlled feasibility study will evalu-
ate the feasibility and acceptability of a multi-component 
behaviour change intervention to increase physical activ-
ity and reduce sedentary behaviour of adults with SMI 
living in rural and semi-rural environments.
Additionally, this study will address the challenges and 
implications of remote delivery of the WORtH interven-
tion due to the COVID-19 pandemic. There is limited 
evidence on the feasibility and acceptability of remotely 
delivered interventions for the management of SMI [51, 
52], and we are not aware of any remotely delivered inter-
ventions aimed at improving physical activity and sed-
entary behaviour in this population. The findings will 
inform the design of a future definitive randomised con-
trolled trial if it is shown to be feasible.
Trial status
This trial is ongoing and open to recruitment.
Table 2 Proposed protocol changes in response to COVID-19
Study activity Measures taken
Recruitment Study information will be shared via email, where possible, or post.
Screening visit will be completed via telephone.
Consent form will be completed and returned by post or email, where possible.
Participants can identify a carer to support them. Carer consent will be obtained.
Rolling recruitment will take place as there will be no group component to the intervention and to reduce clinician burden 
when delivering the intervention.
Randomisation Participants will be randomised at individual level (due to practicalities of rolling recruitment, e.g. to ensure allocation conceal-
ment as participants from the same residential setting may enrol at different times) to either intervention or control group 
in a 2:1 ratio after completion of the baseline assessment. The allocation ratio was changed to ensure sufficient number of 
participants are exposed to the intervention and optimal information on intervention delivery can be collected, given that 
there may be recruitment challenges with remote recruitment and delivery. With 2:1 allocation ratio, two-thirds of participants 
enrolled will be randomised to the intervention group. Allocations will be undertaken using a permuted block design with 
unequal block sizes (of 3, 6, 9). A researcher independent of the study will generate the randomisation sequence and allocate 
the participant after baseline data collection. The randomisation sequence will be concealed from members of the research 
team involved in participant management to prevent biased allocation [47, 48].
Intervention delivery Education session (both intervention and control groups) will be delivered remotely via telephone or video conference 
depending on technology accessible to the individual.
Study materials will be posted to participants.
Instructions will be sent via email or post and the researcher will provide additional instruction via telephone or video call.
Fortnightly coaching calls will be delivered remotely by telephone or video call.
Delivery of the weekly group walk will depend on current guidance regarding physical distancing.
Outcome assessment Participants will be given the option to complete questionnaires via email, post, telephone or video call. This will include 
using alternative versions of tools that are suitable for remote delivery, where required i.e. using the Blind-MoCA, which omits 
requirement of pencil and paper or visual stimulus, and is suitable for telephone administration of the test [49].
Accelerometers will be posted to participants with instructions and the researcher will provide additional instruction via 
telephone or video call.
Anthropometric measures will be collected from patient files, where available.
Exploration of remote methods of collecting data related to functional mobility, i.e. replacing the Timed-Up-and-Go test with a 
remote Sit-to-Stand test [50].
Interviews with participants, clinicians and carers will be carried out by telephone or video call.
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